Sastasundar Ventures Ltd
Sastasundar Ventures Limited is a Core Investment Company (CIC) focusing on the business of digital network of healthcare and portfolio management services. The Company aims to provide healthcare services at a reasonable cost with its innovative information and knowledge based web portal.[1]
- Market Cap ₹ 1,006 Cr.
- Current Price ₹ 316
- High / Low ₹ 507 / 231
- Stock P/E
- Book Value ₹ 235
- Dividend Yield 0.00 %
- ROCE -10.9 %
- ROE -8.57 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company's median sales growth is 42.0% of last 10 years
Cons
- Company has a low return on equity of -7.59% over last 3 years.
- Earnings include an other income of Rs.50.6 Cr.
- Working capital days have increased from 61.2 days to 92.8 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
58 | 47 | 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,382 | |
29 | 32 | 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,377 | |
Operating Profit | 29 | 15 | -4 | -10 | -28 | -20 | -13 | -33 | -52 | -10 | 1,114 | -107 | 5 |
OPM % | 50% | 33% | -15% | -19% | -31% | -15% | -8% | -15% | -13% | -2% | 62% | -10% | 0% |
0 | 0 | 0 | 2 | -0 | 2 | 7 | 0 | 1 | 1 | 3 | -5 | 51 | |
Interest | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 |
Depreciation | 6 | 2 | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 |
Profit before tax | 22 | 13 | -7 | -15 | -37 | -28 | -12 | -42 | -58 | -16 | 1,109 | -122 | 45 |
Tax % | 32% | 31% | 5% | 0% | 1% | -2% | -19% | -3% | 9% | -4% | 22% | 19% | |
14 | 8 | -6 | -15 | -37 | -29 | -15 | -43 | -52 | -17 | 865 | -99 | -64 | |
EPS in Rs | 4.41 | 2.58 | -2.03 | -4.68 | -11.51 | -9.00 | -3.73 | -11.81 | -12.19 | -3.27 | 197.05 | -22.70 | -13.13 |
Dividend Payout % | 23% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 36% |
5 Years: | 46% |
3 Years: | 40% |
TTM: | 56% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -35% |
TTM: | 4% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 21% |
3 Years: | 24% |
1 Year: | 28% |
Return on Equity | |
---|---|
10 Years: | -10% |
5 Years: | -10% |
3 Years: | -8% |
Last Year: | -9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
Reserves | 236 | 245 | 238 | 223 | 186 | 163 | 144 | 106 | 173 | 163 | 790 | 717 | 715 |
6 | 3 | 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 9 | |
44 | 35 | 39 | 22 | 20 | 35 | 48 | 91 | 103 | 85 | 454 | 446 | 435 | |
Total Liabilities | 317 | 315 | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,190 |
19 | 94 | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 106 | |
CWIP | 6 | 8 | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
Investments | 44 | 64 | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 520 |
249 | 148 | 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 564 | |
Total Assets | 317 | 315 | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,190 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-3 | 38 | 36 | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -104 | |
-4 | -8 | -42 | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 124 | |
1 | -19 | -3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -1 | |
Net Cash Flow | -7 | 11 | -10 | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 75 | 59 | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 |
Inventory Days | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | |||
Days Payable | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | |||
Cash Conversion Cycle | 75 | 59 | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 |
Working Capital Days | 1,082 | 417 | 443 | 377 | 247 | 99 | 89 | 61 | 54 | 44 | 46 | 93 |
ROCE % | 9% | 5% | -2% | -6% | -14% | -12% | -8% | -19% | -25% | -6% | -7% | -11% |
Documents
Announcements
- Certificate Under Regulation 40(9) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 1d
-
Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015
2d - Compliance Certificate pursuant to Regulation 7(3) of the SEBI (LODR) Regulations, 2015 for the year ended 31st March, 2024
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
20 Apr - Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2024
- Disclosure Under Regulation 30 Of SEBI (LODR) Reg, 2015 - Subsequent Disclosure On Intimation Of Fraud By Employee(S) Of The Subsidiary Companies 5 Apr
- Intimation Under Regulation 30 Of The SEBI (LODR) Reg, 2015 - Completion Of Tenure Of Independent Director 30 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
Mar 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Sep 2022TranscriptNotesPPT
-
Jun 2022TranscriptNotesPPT
-
Mar 2022TranscriptNotesPPT
-
Dec 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
Leadership
Sastasundar group is #1 pharma distributor in West Bengal.[1]